Marks Group Wealth Management, Inc Laboratory Corp Of America Holdings Transaction History

Marks Group Wealth Management, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$251.87 - $278.14 $5.95 Million - $6.57 Million	-23,636 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$204.88 - $255.03 $425,740 - $529,952	-2,078 Reduced 8.08%	23,636 $6.03 Million
Q4 2020 Feb 08, 2021	SELL	$186.91 - $214.42 $134,762 - $154,596	-721 Reduced 2.73%	25,714 $5.23 Million
Q3 2020 Nov 10, 2020	BUY	$167.03 - $201.3 $312,346 - $376,431	1,870 Added 7.61%	26,435 $4.98 Million
Q2 2020 Aug 10, 2020	SELL	$113.31 - $182.44 $508,082 - $818,060	-4,484 Reduced 15.44%	24,565 $4.04 Million
Q1 2020 Apr 23, 2020	BUY	$104.32 - $195.28 $259,861 - $486,442	2,491 Added 9.38%	29,049 $3.68 Million
Q4 2019 Feb 12, 2020	BUY	$163.48 - $173.61 $4.34 Million - $4.61 Million	26,558 New	26,558 $4.49 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Marks Group Wealth Management, Inc with notifications on news.